Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia - SBTMO/SOPOBE 2020 Consensus Guidelines

SBTMO/SOPOBE Guidelines: Pediatric AML

Authors

  • Ana Luiza de Melo Rodrigues Department of Pediatric Oncology and Bone Marrow Transplant, Hospital Erastinho, Curitiba – PR, Brazil, Department of Internal Medicine/Hematology, Federal University of Paraná (UFPR), Curitiba – PR, Brazil
  • Victor Gottardello Zecchin
  • Maria Lúcia de Martino Lee Department of Pediatric Oncology and Bone Marrow Transplant, Hospital Beneficência Portuguesa, São Paulo – SP, Brazil
  • Antonella Adriana Zanette Department of Pediatric Oncology and Bone Marrow Transplant, Hospital Erastinho, Curitiba – PR, Brazil,
  • Adriana Seber Department of Pediatric Oncology and Bone Marrow Transplant, Hospital Samaritano, São Paulo – SP, Brazil
  • Raul Corrêa Ribeiro Department of Oncology and Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis - TN, USA

DOI:

https://doi.org/10.46765/2675-374X.2021v2n4p139

Keywords:

Hematopoietic Stem Cell Transplantation, Pediatric Acute Myeloid Leukemia, Clinical Guidelines

Abstract

Acute myeloid leukemia (AML) represents 15%–20% of acute leukemias in children, and the risk of treatment failure is based on genetic risk and response to therapy1-4. Although the initial remission rate exceeds 90%, more than 30-40% of children with AML die of refractory/relapsed disease or treatment-related toxicity5. The best therapeutic results are achieved by integrating intensive chemotherapy, optimal supportive care, and hematopoietic stem cell transplant (HSCT) adapted to each patient’s risk of relapse6–9. In 2020, the Brazilian Group for Pediatric Bone Marrow Transplantation of the Brazilian Society of Bone Marrow Transplantation and Cellular Therapy (SBTMO) and the Brazilian Society for Pediatric Oncology (SOBOPE) convened a task force to provide general guidance on HSCT for childhood AML to provide evidence-based guidance for the appropriate management of this disease.

Author Biography

Victor Gottardello Zecchin

Department of Pediatric Oncology and Bone Marrow Transplant, Hospital Beneficência Portuguesa, São Paulo – SP, Brazil

Downloads

Published

11/30/2021

How to Cite

de Melo Rodrigues, A. L., Victor Gottardello Zecchin, Maria Lúcia de Martino Lee, Antonella Adriana Zanette, Adriana Seber, & Raul Corrêa Ribeiro. (2021). Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia - SBTMO/SOPOBE 2020 Consensus Guidelines: SBTMO/SOPOBE Guidelines: Pediatric AML. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2(4), 139. https://doi.org/10.46765/2675-374X.2021v2n4p139

Issue

Vol. 2 No. 4 (2021): JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Section

Original article

License

Copyright (c) 2021 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)